Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy

BACKGROUND: Worldwide, over 10 million individuals suffer from drug-resistant epilepsy. New therapeutic strategies are needed to address this debilitating disease. Inhibition of sodium-glucose linked transporters (SGLTs), which are variably expressed in the brain, has been demonstrated to reduce sei...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdogan, Mumin Alper, Yusuf, Dimas, Christy, Joanna, Solmaz, Volkan, Erdogan, Arife, Taskiran, Emin, Erbas, Oytun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991447/
https://www.ncbi.nlm.nih.gov/pubmed/29879920
http://dx.doi.org/10.1186/s12883-018-1086-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991447/
https://www.ncbi.nlm.nih.gov/pubmed/29879920
http://dx.doi.org/10.1186/s12883-018-1086-4

Ejemplares similares